Recombinant Human COL4a5 Protein，His

COL4A5 is a gene that encodes the alpha-5 chain of type IV collagen, a crucial structural component of the basement membrane in various tissues, including the kidneys, eyes, and skin. Mutations in COL4A5 are mainly associated with Alport syndrome, a genetic disorder characterized by progressive nephritis, sensorineural hearing loss, and ocular abnormalities. Research on the recombinant protein of COL4A5 has become increasingly important as scientists seek to understand its role in tissue integrity and disease progression. Recombinant COL4A5 protein can be used to explore the molecular mechanisms underlying Alport syndrome, investigate the effects of specific mutations, and develop potential therapeutic strategies. By producing the protein in a laboratory setting, researchers can study its interactions with other extracellular matrix components, elucidate its functional properties, and assess the impact of altered collagen structures on cellular behavior. Furthermore, this research has implications not only for understanding Alport syndrome but also for broader applications in tissue engineering and regenerative medicine, where collagen-based scaffolds are utilized to facilitate tissue repair and regeneration. Understanding COL4A5 and its recombinant form aids in identifying biomarkers for diagnosis and prognosis, paving the way for innovative therapeutic approaches to manage and treat associated disorders. This work underscores the significance of collagen biology in health and disease, contributing to the development of effective strategies for tackling collagen-related pathologies.